Colgate restructuring
This article was originally published in The Tan Sheet
Executive Summary
Firm is on track with its current restructuring initiative, which is expected to result in savings of $40 mil.-$50 mil. this year, CEO Reuben Mark reports during a presentation at the Sanford C. Bernstein Strategic Decisions Conference June 1. The plan, announced in December, is aimed at generating savings of $250 mil.-$300 mil. over four years (1"The Tan Sheet" Dec. 13, 2004, p. 14). Colgate will maintain its strategy of focusing on limited categories such as oral care, while "play[ing] down" or divesting other segments, Mark said. The firm will continue to back its oral care franchise with promotional spending despite escalating material costs, the exec notes...
You may also be interested in...
Colgate Strategic Restructuring Aimed At Boosting Ad Spend, Earnings
Colgate is undertaking a four-year restructuring plan aimed at increasing the company's profits by generating annual savings of $250 mil.-$300 mil. after taxes by the fourth year
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.